Global Antibody Drug Conjugates Market Professional Survey Report 2018 - 2025

Description

This report studies the global Antibody Drug Conjugates market status and forecast, categorizes the global Antibody Drug Conjugates market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. 
The preparation process of ADC's involves great difficulty, inspite of these hurdles recently approved ADC's have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC's that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market.
The global Antibody Drug Conjugates market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
F. Hoffman-La Roche
Novartis AG
Takeda Pharmaceutical
Pfizer
Seattle Genetics
Genentech
Immunogen
Progenics Pharmaceuticals
Bayer Healthcare Pharmaceuticals

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Adcetris
Kadcyla

By Application, the market can be split into
Breast Cancer
Lymphoma

The study objectives of this report are:
To analyze and study the global Antibody Drug Conjugates capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Antibody Drug Conjugates manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antibody Drug Conjugates are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Antibody Drug Conjugates Manufacturers
Antibody Drug Conjugates Distributors/Traders/Wholesalers
Antibody Drug Conjugates Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, We offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Antibody Drug Conjugates market, by end-use.
Detailed analysis and profiles of additional market players.

TABLE OF CONTENT

Table of Contents

Global Antibody Drug Conjugates Market Professional Survey Report 2018
1 Industry Overview of Antibody Drug Conjugates
1.1 Definition and Specifications of Antibody Drug Conjugates
1.1.1 Definition of Antibody Drug Conjugates
1.1.2 Specifications of Antibody Drug Conjugates
1.2 Classification of Antibody Drug Conjugates
1.2.1 Adcetris
1.2.2 Kadcyla
1.3 Applications of Antibody Drug Conjugates
1.3.1 Breast Cancer
1.3.2 Lymphoma
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Antibody Drug Conjugates
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antibody Drug Conjugates
2.3 Manufacturing Process Analysis of Antibody Drug Conjugates
2.4 Industry Chain Structure of Antibody Drug Conjugates

3 Technical Data and Manufacturing Plants Analysis of Antibody Drug Conjugates
3.1 Capacity and Commercial Production Date of Global Antibody Drug Conjugates Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Antibody Drug Conjugates Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Antibody Drug Conjugates Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Antibody Drug Conjugates Major Manufacturers in 2017

4 Global Antibody Drug Conjugates Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Antibody Drug Conjugates Capacity and Growth Rate Analysis
4.2.2 2017 Antibody Drug Conjugates Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Antibody Drug Conjugates Sales and Growth Rate Analysis
4.3.2 2017 Antibody Drug Conjugates Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Antibody Drug Conjugates Sales Price
4.4.2 2017 Antibody Drug Conjugates Sales Price Analysis (Company Segment)

5 Antibody Drug Conjugates Regional Market Analysis
5.1 North America Antibody Drug Conjugates Market Analysis
5.1.1 North America Antibody Drug Conjugates Market Overview
5.1.2 North America 2013-2018E Antibody Drug Conjugates Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Antibody Drug Conjugates Sales Price Analysis
5.1.4 North America 2017 Antibody Drug Conjugates Market Share Analysis
5.2 Europe Antibody Drug Conjugates Market Analysis
5.2.1 Europe Antibody Drug Conjugates Market Overview
5.2.2 Europe 2013-2018E Antibody Drug Conjugates Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Antibody Drug Conjugates Sales Price Analysis
5.2.4 Europe 2017 Antibody Drug Conjugates Market Share Analysis
5.3 China Antibody Drug Conjugates Market Analysis
5.3.1 China Antibody Drug Conjugates Market Overview
5.3.2 China 2013-2018E Antibody Drug Conjugates Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Antibody Drug Conjugates Sales Price Analysis
5.3.4 China 2017 Antibody Drug Conjugates Market Share Analysis
5.4 Japan Antibody Drug Conjugates Market Analysis
5.4.1 Japan Antibody Drug Conjugates Market Overview
5.4.2 Japan 2013-2018E Antibody Drug Conjugates Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Antibody Drug Conjugates Sales Price Analysis
5.4.4 Japan 2017 Antibody Drug Conjugates Market Share Analysis
5.5 Southeast Asia Antibody Drug Conjugates Market Analysis
5.5.1 Southeast Asia Antibody Drug Conjugates Market Overview
5.5.2 Southeast Asia 2013-2018E Antibody Drug Conjugates Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Antibody Drug Conjugates Sales Price Analysis
5.5.4 Southeast Asia 2017 Antibody Drug Conjugates Market Share Analysis
5.6 India Antibody Drug Conjugates Market Analysis
5.6.1 India Antibody Drug Conjugates Market Overview
5.6.2 India 2013-2018E Antibody Drug Conjugates Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Antibody Drug Conjugates Sales Price Analysis
5.6.4 India 2017 Antibody Drug Conjugates Market Share Analysis

6 Global 2013-2018E Antibody Drug Conjugates Segment Market Analysis (by Type)
6.1 Global 2013-2018E Antibody Drug Conjugates Sales by Type
6.2 Different Types of Antibody Drug Conjugates Product Interview Price Analysis
6.3 Different Types of Antibody Drug Conjugates Product Driving Factors Analysis
6.3.1 Adcetris Growth Driving Factor Analysis
6.3.2 Kadcyla Growth Driving Factor Analysis

7 Global 2013-2018E Antibody Drug Conjugates Segment Market Analysis (by Application)
7.1 Global 2013-2018E Antibody Drug Conjugates Consumption by Application
7.2 Different Application of Antibody Drug Conjugates Product Interview Price Analysis
7.3 Different Application of Antibody Drug Conjugates Product Driving Factors Analysis
7.3.1 Breast Cancer of Antibody Drug Conjugates Growth Driving Factor Analysis
7.3.2 Lymphoma of Antibody Drug Conjugates Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Antibody Drug Conjugates
8.1 F. Hoffman-La Roche
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 F. Hoffman-La Roche 2017 Antibody Drug Conjugates Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 F. Hoffman-La Roche 2017 Antibody Drug Conjugates Business Region Distribution Analysis
8.2 Novartis AG
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Novartis AG 2017 Antibody Drug Conjugates Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Novartis AG 2017 Antibody Drug Conjugates Business Region Distribution Analysis
8.3 Takeda Pharmaceutical
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Takeda Pharmaceutical 2017 Antibody Drug Conjugates Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Takeda Pharmaceutical 2017 Antibody Drug Conjugates Business Region Distribution Analysis
8.4 Pfizer
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Pfizer 2017 Antibody Drug Conjugates Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Pfizer 2017 Antibody Drug Conjugates Business Region Distribution Analysis
8.5 Seattle Genetics
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Seattle Genetics 2017 Antibody Drug Conjugates Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Seattle Genetics 2017 Antibody Drug Conjugates Business Region Distribution Analysis
8.6 Genentech
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Genentech 2017 Antibody Drug Conjugates Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Genentech 2017 Antibody Drug Conjugates Business Region Distribution Analysis
8.7 Immunogen
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Immunogen 2017 Antibody Drug Conjugates Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Immunogen 2017 Antibody Drug Conjugates Business Region Distribution Analysis
8.8 Progenics Pharmaceuticals
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Progenics Pharmaceuticals 2017 Antibody Drug Conjugates Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Progenics Pharmaceuticals 2017 Antibody Drug Conjugates Business Region Distribution Analysis
8.9 Bayer Healthcare Pharmaceuticals
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Bayer Healthcare Pharmaceuticals 2017 Antibody Drug Conjugates Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Bayer Healthcare Pharmaceuticals 2017 Antibody Drug Conjugates Business Region Distribution Analysis

9 Development Trend of Analysis of Antibody Drug Conjugates Market
9.1 Global Antibody Drug Conjugates Market Trend Analysis
9.1.1 Global 2018-2025 Antibody Drug Conjugates Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Antibody Drug Conjugates Sales Price Forecast
9.2 Antibody Drug Conjugates Regional Market Trend
9.2.1 North America 2018-2025 Antibody Drug Conjugates Consumption Forecast
9.2.2 Europe 2018-2025 Antibody Drug Conjugates Consumption Forecast
9.2.3 China 2018-2025 Antibody Drug Conjugates Consumption Forecast
9.2.4 Japan 2018-2025 Antibody Drug Conjugates Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Antibody Drug Conjugates Consumption Forecast
9.2.6 India 2018-2025 Antibody Drug Conjugates Consumption Forecast
9.3 Antibody Drug Conjugates Market Trend (Product Type)
9.4 Antibody Drug Conjugates Market Trend (Application)

10 Antibody Drug Conjugates Marketing Type Analysis
10.1 Antibody Drug Conjugates Regional Marketing Type Analysis
10.2 Antibody Drug Conjugates International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Antibody Drug Conjugates by Region
10.4 Antibody Drug Conjugates Supply Chain Analysis

11 Consumers Analysis of Antibody Drug Conjugates
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Antibody Drug Conjugates Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

Choose License Type

Checkout Inquiry